foxo4 dri experience FOXO4-DRI 10mg vial - Description Peptide inhibitors targeting FOXO4-p53 interactions

NCT04892136 (hair growth, Phase I/II, terminated 2023) clinicaltrials.gov

Community protocols then increase to 0.5 mg 3x weekly (1.5 mg total weekly) when well-tolerated

Early reports suggest possible benefits in conditions such as psoriasis and hidradenitis suppurativa, especially in patients who also have obesity, insulin resistance or type 2 diabetes

This tripeptide binds copper ions to support collagen and elastin production, enhance wound healing, and promote cellular regeneration

BPC-157 20mg Strength: 20 mg CAS: 137525-51-0 Chemical Formula: CHNO Molecular weight: 1419.5 g/mol Peptide Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val Synonyms: BPC157, Bepecin Storage: Store 28 C (20 C long-term)